Ocrelizumab Provides Superior Relapse Control in Multiple Sclerosis

THURSDAY, Oct. 2, 2025 (HealthDay News) -- For patients with relapse-onset multiple sclerosis (MS), ocrelizumab provides superior control of relapse compared wi